Insider Stock Trading History of Nova Tina Susan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Nova Tina Susan since year 2005. The trader's CIK number is 1302605. At the time of this reporting, Nova Tina Susan is the President and CEO of Arena Pharmaceuticals Inc . (stock ticker symbol ARNA). See this page for all insider trading activities at Arena Pharmaceuticals Inc .

Note that in the past Nova Tina Susan also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Nova Tina Susan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-04-14 ARNA Arena Pharmaceuticals Inc Option Ex 35,000 5.14 179,725
2014-04-14 ARNA Arena Pharmaceuticals Inc Sale 35,000 6.22 217,770
2011-02-26 GXDX Genoptix Inc Option Ex 279,491 7.32 2,044,476
2010-11-10 GXDX Genoptix Inc Sale 1,624 17.68 28,710
2010-11-10 GXDX Genoptix Inc Option Ex 1,624 9.50 15,428
2010-04-06 GXDX Genoptix Inc Option Ex 20,900 .81 16,929
2010-04-06 GXDX Genoptix Inc Sale 20,900 36.45 761,867
2010-03-03 GXDX Genoptix Inc Sale 16,700 31.90 532,746
2010-03-03 GXDX Genoptix Inc Option Ex 16,700 .81 13,527
2010-02-03 GXDX Genoptix Inc Option Ex 16,700 .81 13,527
2010-02-03 GXDX Genoptix Inc Sale 16,700 31.13 519,854
2010-01-06 GXDX Genoptix Inc Option Ex 20,900 .81 16,929
2010-01-06 GXDX Genoptix Inc Sale 20,900 35.06 732,858
2009-09-03 GXDX Genoptix Inc Option Ex 12,519 .38 4,757
2009-09-03 GXDX Genoptix Inc Sale 12,519 30.03 375,958
2009-08-05 GXDX Genoptix Inc Option Ex 15,259 .38 5,798
2009-08-05 GXDX Genoptix Inc Sale 15,259 30.34 463,003
2009-07-06 GXDX Genoptix Inc Option Ex 9,259 .38 3,518
2009-07-06 GXDX Genoptix Inc Sale 9,259 27.50 254,603
2009-06-03 GXDX Genoptix Inc Sale 9,259 29.64 274,399
2009-06-03 GXDX Genoptix Inc Option Ex 9,259 .38 3,518
2009-05-05 GXDX Genoptix Inc Sale 9,259 28.37 262,696
2009-05-05 GXDX Genoptix Inc Option Ex 9,259 .38 3,518
2009-04-03 GXDX Genoptix Inc Option Ex 9,259 .38 3,518
2009-04-03 GXDX Genoptix Inc Sale 9,259 29.01 268,603
2009-03-04 GXDX Genoptix Inc Sale 9,259 27.83 257,715
2009-03-04 GXDX Genoptix Inc Option Ex 9,259 .38 3,518
2009-02-04 GXDX Genoptix Inc Sale 18,518 33.74 624,871
2009-02-04 GXDX Genoptix Inc Option Ex 18,518 .38 7,036
2009-01-06 GXDX Genoptix Inc Sale 18,518 31.97 592,057
2009-01-06 GXDX Genoptix Inc Option Ex 18,518 .81 14,999
2008-03-05 GXDX Genoptix Inc Sale 118,212 25.50 3,014,406
2008-02-28 GXDX Genoptix Inc Option Ex 117,542 .81 95,209

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nova Tina Susan (President and CEO of Arena Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.